Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities.
Angiogenin, a potent inducer of neovascularization in the chicken chorioallantoic membrane and rabbit cornea, promotes endothelial cell invasion of Matrigel basement membrane. A transformed bovine aortic endothelial cell line, GM 7373, is 5 times more invasive when cultured in the presence of 1 microgram of bovine angiogenin per ml than in its absence. A polyclonal anti-angiogenin antibody and alpha 2-antiplasmin neutralize the effect of angiogenin, but an angiogenin-binding protein (actin) does not. Further, this concentration of angiogenin induces a 14-fold increase in the cell-associated proteolytic activity of cultured endothelial cells, determined with a tissue-type plasminogen activator-specific peptide as the substrate. In addition, cells cultured on a three-dimensional fibrin gel in the presence of angiogenin are 3 times more capable of dissolving the gel and forming focal defects in the underlying matrix. The results indicate that angiogenin can enhance the ability of endothelial cells to digest extracellular matrix components and degrade basement membrane, thereby facilitating cell invasion and migration. Binding of angiogenin to its cell-surface binding protein (actin) followed by dissociation of the angiogenin-actin complex from the cell surface and subsequent activation of tissue-type plasminogen activator/plasmin are likely steps involved in the processes of endothelial cell invasion and angiogenesis.
Hu
G
G
Center for Biochemical and Biophysical Sciences and Medicine, Harvard Medical School, Boston, MA 02115.
Riordan
J F
JF
Vallee
B L
BL
D043925:Angiogenesis Inducing Agents / Q000494:pharmacology; D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D001011:Aorta; D001485:Basement Membrane / Q000502:physiology; D002417:Cattle; D002465:Cell Movement; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D010450:Endopeptidases / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000201:enzymology / Q000502:physiology*; D005109:Extracellular Matrix / Q000502:physiology*; D005260:Female; D008892:Milk; D011506:Proteins / Q000302:isolation & purification / Q000494:pharmacology*; D011651:Pulmonary Artery; D012259:Ribonuclease, Pancreatic; D010959:Tissue Plasminogen Activator / Q000378:metabolism*
D043925:Angiogenesis Inducing Agents; D000906:Antibodies; D011506:Proteins; C046366:angiogenin; D012259:Ribonuclease, Pancreatic; D010450:Endopeptidases; D010959:Tissue Plasminogen Activator